Recurrent Epstein-Barr virus associated lesions in organ transplant recipients

被引:69
作者
Wu, TT
Swerdlow, SH
Locker, J
Bahler, D
Randhawa, P
Yunis, EJ
Dickman, PS
Nalesnik, MA
机构
[1] UNIV PITTSBURGH,MED CTR,DIV TRANSPLANTAT PATHOL,PITTSBURGH,PA 15261
[2] UNIV PITTSBURGH,MED CTR,DIV HEMATOPATHOL,PITTSBURGH,PA 15261
[3] UNIV PITTSBURGH,MED CTR,DIV MOLEC PATHOL,PITTSBURGH,PA 15261
[4] UNIV PITTSBURGH,MED CTR,DIV PEDIAT PATHOL,PITTSBURGH,PA 15261
[5] UNIV PITTSBURGH,CHILDRENS HOSP PITTSBURGH,SCH MED,PITTSBURGH,PA
基金
美国国家卫生研究院;
关键词
Epstein-Barr virus; organ transplantation; lymphoproliferative disorders;
D O I
10.1016/S0046-8177(96)90369-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Posttransplant lymphoproliferative disorders (PTLD) are related to Epstein-Barr virus (EBV) and range from lymphoid hyperplasias to lymphomas. The authors report 11 transplant recipients with recurrent EBV-associated lesions. Four patients presented with EBV-positive mononucleosis-like lymphadenitis. One had recurrence of a similar lesion and the other three developed polymorphic PTLDs. Matched clonal studies in one patient showed clonal lymphoid and EB viral populations in the recurrent lesion, but not in the initial lesion. Six patients presented with polymorphic PTLDs. Five later developed histologically dissimilar tumors that resembled non-Hodgkin's lymphoma (two B-cell and one T-cell origin), Hodgkin's disease (one patient), or smooth muscle tumor (one patient). Matched clonal studies were available from one patient and showed that the primary and recurrent lesions were clonally distinct. The sixth patient had recurrence of histologically and clonally identical polymorphic PTLD. One patient presented with monomorphic PTLD and developed recurrence of a clonally identical tumor after a B-month remission. This study shows that a few patients with EBV-associated lesions have clinical recurrence, which may be either a relapse of the original process or a new EBV-associated lesion. In some patients, the new lesion appeared to represent a more fully developed malignancy than did the antecedent lesion. Copyright (C) 1996 by W.B. Saunders Company.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 29 条
[1]  
ARMITAGE JM, 1991, J HEART LUNG TRANSPL, V10, P877
[2]  
BAHLER DW, 1992, AM J PATHOL, V140, P1
[3]   THERAPY FOR TRANSPLANT-RELATED LYMPHOPROLIFERATIVE DISEASES [J].
BENKERROU, M ;
DURANDY, A ;
FISCHER, A .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :467-475
[4]  
CLEARY ML, 1988, BLOOD, V72, P349
[5]   PROTECTION OF COTTONTOP TAMARINS AGAINST EPSTEIN-BARR VIRUS-INDUCED MALIGNANT-LYMPHOMA BY A PROTOTYPE SUBUNIT VACCINE [J].
EPSTEIN, MA ;
MORGAN, AJ ;
FINERTY, S ;
RANDLE, BJ ;
KIRKWOOD, JK .
NATURE, 1985, 318 (6043) :287-289
[6]  
FRIZZERA G, 1981, CANCER RES, V41, P4262
[7]  
FRIZZERA G, 1992, NEOPLASTIC HEMATOPAT, P459
[8]   EPSTEIN-BARR VIRUS-INDUCED B-CELL LYMPHOMA AFTER RENAL-TRANSPLANTATION - ACYCLOVIR THERAPY AND TRANSITION FROM POLYCLONAL TO MONOCLONAL B-CELL PROLIFERATION [J].
HANTO, DW ;
FRIZZERA, G ;
GAJLPECZALSKA, KJ ;
SAKAMOTO, K ;
PURTILO, DT ;
BALFOUR, HH ;
SIMMONS, RL ;
NAJARIAN, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (15) :913-918
[9]  
HANTO DW, 1981, CANCER RES, V41, P4253
[10]  
KNOWLES DM, 1995, BLOOD, V85, P552